Khoylou Marta Ph.D.
Journals
        Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.        
                  Theranostics.                
                  2022,
                
                              12(17),
                  
                              7203-7215,
                          
                  ISSN: 1838-7640,
                
                
                              PMID: 36438496,                          
                
                          
        
      
    
        Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival.        
                  Translational Lung Cancer Research.                
                  2022,
                
                              11(10),
                  
                              2040-2050,
                          
                  ISSN: 2218-6751,
                
                
                              PMID: 36386452,                          
                
                          
        
      
    Books & book chapters
        Detekce nádorových biomarkerů v molekulárně biologické laboratoři,
        
                  1. vyd,
                
                  Olomouc,
                
                  Univerzita Palackého v Olomouci,
        
                  2012,
        
                              144 s,
                          
                              Dedication: MOLONKOL CZ.1.07/2.3.00/09.0089,
                          
                  ISBN: 978-80-244-3002-7,
                
        
      
    Intellectual property
        METHOD OF DETERMINING SENSITIVITY OF PATIENTS WITH TUMOROUS DISEASE TO TREATMENT WITH HER-2 RECEPTOR INHIBITORS (Hajdúch)
        
    - Patent: CZ 302709; Granted: 3.8.2011; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
- Published Application PCT/CZ2009/000006 under WO2009/092338 (30.7.2009)
- Patent: US 8,465,936; Granted: 18.6.2013; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
- Patent: JP 5295268; Granted: 21.6.2013; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
- Patent: EP 2241890; Granted: 9.4.2014; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
Status: Terminated
Master mentorship
Jenčíková Barbora
Expression of opioid receptors and its influence on the treatment of gastrointestinal cancer patients
        Status:
        Graduated from 2015 to 2017.
      
      Bachelor mentorship
Míšek David
Expression of matrix metalloproteinases in tubular adenomas compared to expression in colorectal carcinomas
        Status:
        Graduated from 2015 to 2016.
      
      Hrušková Eva B.Sc.
The role of metalloproteinases in the process of tumor progression in patients with colorectal carcinoma.
        Status:
        Graduated from 2013 to 2013.
      
      Jenčíková Barbora
Prognostic and predictive significance of matrix metalloproteinases in patients with colorectal cancer
        Status:
        Graduated from 2013 to 2015.
      
       
         
               
               
               
